Zensun Enterprises Limited (ZENSUN ENT, 00185) has issued a circular outlining resolutions to be tabled at its Annual General Meeting (AGM) scheduled for 12 June 2026 in Zhengzhou, Henan Province.
Key proposals
1. Share issuance mandate • Board request: a general mandate authorising directors to allot, issue or deal with up to 20% of existing issued shares, equivalent to 382.68 million shares based on the 1.91 billion shares outstanding as at 15 April 2026. • Extension mandate: any shares repurchased under the buy-back mandate may be added to the issuance limit.
2. Share buy-back mandate • Authority sought to repurchase up to 10% of issued share capital, or 191.34 million shares, on the Stock Exchange or other recognised bourses. • Repurchases will be financed from available cash or working-capital facilities and conducted within Hong Kong legal and Listing Rules constraints. • The board affirms it will avoid reducing public float below the 25% regulatory threshold; no share repurchases occurred in the six months to 15 April 2026.
3. Director re-elections • Non-executive director Ms Huang Yanping and independent non-executive director Mr Ma Yuntao will retire by rotation and stand for re-election. • The nomination committee endorses both candidacies; Mr Ma’s independence has been reconfirmed despite over nine years of service. • Ms Huang is the spouse of Chairman and CEO Mr Zhang Jingguo and holds an indirect 71.99% interest (1.38 billion shares) in ZENSUN ENT through Joy Town Inc. and related entities. • Service terms: Ms Huang—HKD 1 annual fee; Mr Ma—HKD 0.12 million per annum.
4. Auditor re-appointment • Prism Hong Kong Limited is nominated for re-appointment as external auditor for FY 2026, with the board authorised to fix remuneration.
Key dates
• Register closure: 8–12 June 2026 (both dates inclusive) for determining AGM eligibility; last day to lodge transfers is 5 June 2026. • AGM: 10:30 a.m., 12 June 2026, 37/F, Zensun International Building, Zhengzhou. • Proxy submissions: due by 10 June 2026, 10:30 a.m.
If approved, the mandates will remain effective until the earlier of the next AGM, the expiry of the statutory period for holding the next AGM, or revocation by shareholders.